These life-science stocks provide biotech-like performance without the gyrations

Life-science equipment-and-service providers have retuned as much as 60% this year. By Phil van Doorn.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.